Literature DB >> 351447

Minoxidil therapy in refractory hypertension analysis of 155 patients.

G W Keusch, P Weidmann, V Campese, D B Lee, A T Upham, S G Massry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 351447     DOI: 10.1159/000181366

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

Review 1.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

2.  Minoxidil and captopril in severe hypertension.

Authors:  P Greminger; E Foerster; H Vetter; P Baumgart; W Vetter
Journal:  Klin Wochenschr       Date:  1986-04-01

3.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

4.  Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.

Authors:  M G Bianchetti; P Weidmann; K Boehringer; L Link; H Schiffl; C Beretta-Piccoli; J P Colombo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volume.

Authors:  M Grimm; P Weidmann; A Meier; H Schiffl; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.

Authors:  A Meier; P Weidmann; W H Ziegler
Journal:  Klin Wochenschr       Date:  1981-11-16

Review 7.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.